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Evidence indicates that gaining weight in adult life is associated with an elevated risk of colorectal cancer; however, biological mechanisms that may explain this association remain unclear. We evaluated the mediation effect of 20 different biomarkers on the relationship between adult weight gain and colorectal cancer, using data from a prospective nested case-control study of 452 incident cases diagnosed between 1992 and 2003 and matched within risk sets to 452 controls within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The proportions of mediated effects (%) were estimated on the basis of differences in percent effect changes in conditional logistic regression models with and without additional adjustment for individual biomarkers. Greater adult weight gain (≥300 g/year vs. <300 g/year) was associated with a higher risk of colon cancer (multivariableadjusted relative risk = 1.54, 95% confidence interval: 1.07, 2.24) but not rectal cancer (relative risk = 1.07, 95% confidence interval: 0.68, 1.66). This association was accounted for mostly by attained waist circumference (reduction of 61%) and by the biomarkers soluble leptin receptor (reduction of 43%) and glycated hemoglobin (reduction of 28%). These novel data suggest that the observed association between adult weight gain and colon cancer could be primarily explained by attained abdominal fatness and biomarkers of metabolic dysfunction. adiposity; adult weight gain; colorectal cancer; metabolic mediators Abbreviations: BMI, body mass index; CRP, C-reactive protein; DV, dependent variable; EPIC, European Prospective Investigation Into Cancer and Nutrition; FRAP, ferric reducing ability of plasma; HbA1c, hemoglobin A 1c ; HMW, high-molecularweight; IV, independent variable; MV, mediating variable; ROM, reactive oxygen metabolites; sOB-R, soluble leptin receptor.
A growing body of evidence has emerged consistently suggesting that high body weight gain during adulthood is associated with a greater risk of colorectal cancer. In recent meta-analyses that quantified this association, investigators reported a somewhat stronger risk for colon cancer than for rectal cancer, independent of body weight at younger ages and established colorectal cancer risk factors (1) (2) (3) . While the evidence in support of this association is growing, valid questions, such as whether weight gain per se promotes colorectal cancer and what exact mechanisms may underline this association, remain unanswered.
Anthropometric indicators of attained adiposity, such as body mass index (BMI), reflect both lean body mass and adipose mass, whereas weight gain in adult life is more likely a gain of body fat and thus may potentially represent age-related metabolic changes (4) . A number of metabolic biomarkers have been suggested to play an important role in colon carcinogenesis, including biomarkers of hyperinsulinemia (C-peptide) (5), hyperglycemia (hemoglobin A 1c (HbA1c) or glycated hemoglobin) (6) , and dyslipidemia (high-density lipoprotein cholesterol) (7) . In addition, insulin and insulin-like growth factor axes are major determinants of proliferation and apoptosis and thus may also influence carcinogenesis of the colon (8, 9) . A recent study demonstrated the role of adipose-tissue-derived hormones-adiponectin and soluble leptin receptor (sOB-R)-as mediators of the association between adiposity and colon cancer risk (10) . Furthermore, evidence indicates that chronic inflammation and oxidative stress are important factors in the development of carcinogenesis (11, 12) . In particular, C-reactive protein (CRP) as a biomarker of chronic lowgrade inflammation (13) and biomarkers of increased production of nitrogen or reactive oxygen species have been associated with risk of colorectal cancer (14) . Moreover, low circulating levels of 25-hydroxyvitamin D, the accepted biomarker of vitamin D status, has been also implicated in immunity and inflammation (15, 16) and has been recently established as a risk factor for colorectal cancer (17, 18) . Finally, iron metabolism biomarkers could also play a role in colorectal cancer development due to their proinflammatory and prooxidant activities (19, 20) .
Based on this knowledge, we hypothesized that high body weight gain in adult life is associated with chronic inflammation and metabolic dysfunction and thereby contributes to colorectal carcinogenesis. We aimed to investigate whether the association between high adult weight gain and risk of colorectal cancer may be mediated by attained adiposity and metabolic biomarkers, using a nested case-control study carried out within the European Prospective Investigation Into Cancer and Nutrition (EPIC) cohort.
METHODS

Study population
EPIC is a large prospective study with approximately 520,000 participants who were aged 25-70 years at enrollment during the period 1992-2000 and were recruited from 23 centers in 10 European countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom) (21, 22) . Participants gave written informed consent, anthropometric measurements were performed by trained personnel, and questionnaires were completed on sociodemographic and lifestyle characteristics, including a detailed assessment of diet (22) . Approval was obtained from the ethics review board of the International Agency for Research on Cancer (Lyon, France) and the local review boards pertaining to the participating institutions. The present analysis was based on participants' data from study centers in Denmark, Germany (Potsdam), Greece, Italy (Naples, Varese), and the United Kingdom, with available information on recalled body weight at age 20 years, anthropometric characteristics at study enrollment, and available biomarker assessments. Body weight and waist circumference were mostly measured, with the exception of the Oxford, United Kingdom, study center, where weight and waist circumference were derived from prediction equations based on the self-reports of all participants and measurements taken in a subsample of the Oxford cohort. The anthropometric measurements were corrected to reduce heterogeneity due to protocol differences in clothing worn during measurement, as previously described (23) .
Definition of high weight gain
Adult weight gain was defined as the difference between measured weight at study enrollment (at an average participant age of 59 years) and recalled weight at age 20 years reported in baseline questionnaires, as described previously (24) . Adult weight gain was assessed as kilograms gained per year for the period between age 20 years and study enrollment. We defined high adult weight gain as a weight gain of 300 g/year or more, which corresponds to approximately a 1-standard-deviation increase in the controls. The average period of weight-gain history assessment in the study participants (from age 20 years to age at study enrollment) was approximately 40 years.
Cohort follow-up and case ascertainment
Closure dates for the present study were defined as the latest date of complete follow-up for both cancer incidence and vital status, and ranged from December 1999 to June 2003 for centers using registry data and from June 2000 to December 2002 for centers using active follow-up procedures. For the present study, colon cancers were defined as tumors of the cecum, appendix, ascending colon, hepatic flexure, transverse colon, splenic flexure, and descending and sigmoid colon according to the International Classification of Diseases, Tenth Revision (codes C18.0-C18.7), as well as tumors that were overlapping or unspecified (codes C18.8 and C18.9); rectal tumors were defined as those occurring at the rectosigmoid junction (code C19) or in the rectum (code C20). Incident cancer cases were identified through record linkage with regional cancer registries or using a combination of methods, including health insurance records, cancer and pathology registries, and active follow-up through study subjects and their next of kin.
Nested case-control study A total of 452 incident colorectal cancer cases (266 colon, 186 rectum) were included in the present analyses. An incidence density sampling protocol was used such that for each case, 1 control subject was chosen at random among appropriate risk sets consisting of all cohort members who were alive and free of cancer (except nonmelanoma skin cancer) at the time of diagnosis of the index case. Matching characteristics were study center at the time of enrollment, sex, age at blood collection, time of blood collection, and fasting status. Women were also matched on menopausal status (premenopausal, perimenopausal, postmenopausal, or surgically postmenopausal). Premenopausal women were matched on phase of the menstrual cycle at blood collection (early follicular, late follicular, ovulatory, early luteal, midluteal, or late luteal), and postmenopausal women were matched on current use of hormone replacement therapy (yes/no).
Biomarker assessment
In the EPIC study, blood samples were collected from about 65% of women and 93% of men and were processed, aliquoted into heat-sealed straws, and stored in liquid nitrogen freezers (−196°C) (25) . Storage protocols differed in Denmark and Sweden, where tubes were stored in the vapor phase of liquid nitrogen (−150°C) or in freezers (−80°C), respectively. The blood collection and processing protocols are described in detail elsewhere (22) . Measurement of all biomarkers included in the analysis-including CRP (13) as a biomarker of low-grade inflammation, the metabolic biomarkers (C-peptide (5), HbA1c (6), insulin-like growth factor 1 (9), adiponectin and high-molecular-weight (HMW) adiponectin (26) , triglycerides (7), total, high-density lipoprotein, and low-density lipoprotein cholesterol (7), leptin (27) , and sOB-R (27)), the oxidative stress biomarkers (reactive oxygen metabolites (ROM) and ferric reducing ability of plasma (FRAP)) (14) , and biomarkers of vitamin D metabolism (25-hydroxyvitamin D (18) and parathyroid hormone (28))-has been described elsewhere. Measurements of biomarkers of iron metabolism (serum iron and transferrin concentrations) were taken with a clinical chemical autoanalyzer (Hitachi 912; Roche Diagnostics, Mannheim, Germany). Serum ferritin was determined with a dedicated immunoanalyzer (Access 2 Immunoassay System; Beckman Coulter Inc., Bilthoven, the Netherlands). In a pretest study, these biomarkers showed good reliability when evaluated several years apart (29) .
Statistical analyses
Case-control differences in sociodemographic, lifestyle, anthropometric, and potentially mediating factors were assessed using Student's paired t test and Wilcoxon's signed-rank test for continuous variables and McNemar's and Bowker's test of symmetry for categorical variables. Because of the large number of participants excluded from the current analyses due to missing information on weight at age 20 years and missing biomarker measurements (n = 537), we compared baseline characteristics of participants with and without missing data.
The potential mediating factors were selected following the formal criteria of Baron and Kenny (30, 31) ; namely these were metabolic factors related to high adult weight gain and previously reported to be independently associated with colorectal cancer risk. In order to assess mediation, we applied the "causal steps approach" as previously described (30-32):
1. Prove a statistically significant relationship between the IV and the DV. 2. Demonstrate that variations in levels of the IV significantly account for the variations in the presumed MV. 3. Check to see whether variations in the MV significantly account for variations in the DV independently of IV (when both the IV and the MV are predictors of the DV). 4. Quantify the value of the mediated effect. The value of the mediated or indirect effect is estimated using a method originally proposed by Freedman et al. (33), by taking the difference between the coefficients,ĉ −ĉ′, that corresponds to the reduction in the IV effect on the DV when adjusted for MV. Note that when a mediation effect exists when both the IV and the MV appear in the model, a previously significant relationship between the IV and the DV would no longer be significant.
In step 1, we evaluated the association between high adult weight gain (IV) and colon and rectal cancer (DV) using multivariable conditional logistic regression analyses. Relative risks, estimated from odds ratios as derived from the risk set sampling design (34) , and 95% confidence intervals were computed. The multivariable model adjusted for education and for established colorectal cancer risk factors, including smoking status (never smoker, past smoker, current smoker, or unknown), alcohol intake (g/day), and physical activity (inactive, moderately inactive, moderately active, active, or missing). Further adjustment for weight at age 20 years and dietary factors known to be associated with colorectal cancer risk-intakes of fish and shellfish (g/day), red and processed meat (g/day), fiber (g/day), and fruits and vegetables (g/day)-did not substantially change the risk estimates (<10%); therefore, we did not include these variables in the final multivariable model. We evaluated weight gain both as total weight gain and as yearly weight gain; however, because of the similar findings, we present mediation analysis results only for weight gain per year. Since no association with rectal cancer was observed (see below), the subsequent mediation steps were followed only for colon cancer as the DV.
In step 2, we estimated Spearman partial correlation coefficients, adjusted for age at study recruitment and sex, to assess the correlations between high adult weight gain (IV) and each of the metabolic factors (MV) among controls.
In step 3, we evaluated associations of metabolic factors (MV) with risk of colon cancer (DV) in a multivariableadjusted model with additional adjustment for high adult weight gain (IV).
In step 4, we calculated the mediation effects of the individual metabolic factors by adding each metabolic factor (MV) to the multivariable-adjusted model and estimated the percent effect change in the regression coefficients (β coefficients), based on the formula β indirect effect = [(β − β 1 )/β] × 100 (32, 33) (see above). In order to evaluate the significance of the observed effect changes, we calculated corresponding 95% confidence intervals based on Fieller's theorem (35) . Note that although the term "effect" is used in the original description of mediation analyses, observational research provides estimates of associations by means of relative risks, and this term does not necessarily imply causality.
In sensitivity analyses, we repeated the main multivariableadjusted analysis after excluding cases diagnosed during the first 2 years of follow-up (n = 72), participants with diabetes (n = 25), and nonfasting participants (n = 97). Two-sided P values less than 0.05 were considered to indicate statistical significance. All statistical analyses were performed using Statistical Analysis System software, version 9.2 (SAS Institute, Inc., Cary, North Carolina).
RESULTS
The baseline characteristics of incident cases of colon and rectal cancer and their corresponding controls are presented in Table 1 . Colon cancer cases were more likely to be smokers, to be physically inactive, to have higher alcohol consumption, and to have higher BMI and waist circumference compared with the controls (Table 1) . On average, colon cancer cases gained more weight than controls (14.1 kg (standard deviation, 10) vs. 12.4 kg (standard deviation, 9.7), respectively), whereas no statistically significant differences were seen for rectal cancer cases. Compared with controls, colon cancer cases had higher concentrations of CRP, HbA1c, leptin, low-density lipoprotein cholesterol, ROM, FRAP, parathyroid hormone, and transferrin and had lower concentrations of sOB-R, vitamin D, and ferritin. Rectal cancer cases had lower adiponectin and higher ROM concentrations than their respective controls. When we compared descriptive characteristics between participants included in the analysis and participants excluded because of missing information, no substantial overall differences were seen except that the population included in our analysis was older (an average age of 59 years as compared with 50 years). In the multivariableadjusted model, high adult weight gain was associated with a greater risk of colon cancer (for weight gain ≥300 g/year vs. <300 g/year, relative risk = 1.54, 95% confidence interval: 1.06, 2.24; P = 0.02), whereas no association was observed for rectal cancer (relative risk = 1.07, 95% confidence interval: 0.68, 1.66; P = 0.76). Table 2 presents the cross-sectional associations between high adult weight gain and potentially mediating variables among controls. Overall, high adult weight gain was correlated with the majority of investigated factors except for insulin-like growth factor 1, total cholesterol, low-density lipoprotein cholesterol, and ferritin. Most of the associations were of moderate strength. Stronger correlations (r s > 0. 20) were observed for the measures of attained adiposity (BMI and waist circumference) and for the biomarkers-CRP, C-peptide, adiponectin, HMW adiponectin, leptin, sOB-R, high-density lipoprotein cholesterol, triglycerides, and FRAP. Table 3 presents the results for the association between individual biomarkers (continuously per doubling of concentrations) and risk of colon cancer. In a multivariable model that additionally adjusted for high adult weight gain, most of the investigated biomarkers were associated with Abbreviations: BMI, body mass index; CI, confidence interval; CRP, C-reactive protein; EPIC, European Prospective Investigation Into Cancer and Nutrition; FRAP, ferric reducing ability of plasma; HbA1c, hemoglobin A 1c ; HDL, high-density lipoprotein; HMW, high-molecular-weight; IGF-1, insulin-like growth factor 1; LDL, low-density lipoprotein; PTH, parathyroid hormone; ROM, reactive oxygen metabolites; sOB-R, soluble leptin receptor.
a Adjusted for the following matching factors: age, sex, study center, follow-up time since blood collection, time of day at blood collection, and fasting status; women were further matched on menopausal status and phase of the menstrual cycle at blood collection, and postmenopausal women were matched on use of hormone replacement therapy. The model was further adjusted for education (no school degree or primary school, technical or professional school, secondary school, university degree, or unknown), smoking status (never, past, current, or unknown), alcohol intake (g/day; continuous), and physical activity (inactive, moderately inactive, moderately active, active, or missing).
b High adult weight gain was defined as weight gain of ≥300 g/year, which corresponds to approximately a 1-standard-deviation increase in the EPIC study population. Adult weight gain was assessed as an absolute estimate of kilograms gained for the period between age 20 years and study enrollment and as kilograms gained per year (for the same period). The average period of assessment of weight-gain history in the study participants (from age 20 years to age at study enrollment) was approximately 40 years. the risk of colon cancer, with the exception for insulin-like growth factor 1, total adiponectin, HMW adiponectin, triglycerides, cholesterol, low-density lipoprotein cholesterol, and parathyroid hormone. Table 4 presents the results from the mediation analyses in which we assessed the association of colon cancer with high adult weight gain and estimated the percent changes in regression coefficients after adjustment for each of the metabolic factors. In these analyses, the highest percent change in the association between high weight gain and colon cancer was observed for attained waist circumference (reduction of 61%), sOB-R (reduction of 43%), and HbA1c (reduction of 28%). Other factors that showed an influence on the association included the iron metabolism biomarker transferrin (reduction of 17%) and the biomarkers of oxidative stress-ROM (reduction of 11%) and FRAP (reduction Abbreviations: CI, confidence interval; CRP, C-reactive protein; EPIC, European Prospective Investigation Into Cancer and Nutrition; FRAP, ferric reducing ability of plasma; HbA1c, hemoglobin A 1c ; HDL, high-density lipoprotein; HMW, high-molecular-weight; IGF-1, insulin-like growth factor 1; LDL, low-density lipoprotein; PTH, parathyroid hormone; ROM, reactive oxygen metabolites; RR, relative risk; sOB-R, soluble leptin receptor.
a The multivariable-adjusted model in conditional logistic regression took into account the following matching factors: age, sex, study center, follow-up time since blood collection, time of day at blood collection, and fasting status; women were further matched on menopausal status and phase of the menstrual cycle at blood collection, and postmenopausal women were matched on use of hormone replacement therapy. The model was further adjusted for education (no school degree or primary school, technical or professional school, secondary school, university degree, or unknown), smoking status (never, past, current, or unknown), alcohol intake (g/day; continuous), and physical activity (inactive, moderately inactive, moderately active, active, or missing).
b High adult weight gain was defined as weight gain of ≥300 g/year, which corresponds to approximately a 1-standard-deviation increase in the EPIC study population. Adult weight gain was assessed as an absolute estimate of kilograms gained for the period between age 20 years and study enrollment and as kilograms gained per year (for the same period). The average period of assessment of weight-gain history in the study participants (from age 20 years to age at study enrollment) was approximately 40 years. Abbreviations: BMI, body mass index; CI, confidence interval; CRP, C-reactive protein; EPIC, European Prospective Investigation Into Cancer and Nutrition; FRAP, ferric reducing ability of plasma; HbA1c, hemoglobin A 1c ; HDL C, high-density lipoprotein cholesterol; IGF-1, insulin-growth factor; LDL, low-density lipoprotein; PTH, parathyroid hormone; ROM, reactive oxygen metabolites; RR, relative risk; sOB-R, soluble leptin receptor.
a High adult weight gain was defined as weight gain of ≥300 g/year, which corresponds to approximately a 1-standard-deviation increase in the EPIC study population. Adult weight gain was assessed as an absolute estimate of kilograms gained for the period between age 20 years and study enrollment and as kilograms gained per year (for the same period). The average period of assessment of weight-gain history in the study participants (from age 20 years to age at study enrollment) was approximately 40 years.
b The β coefficient (regression coefficient) is the natural log of the RR estimate. c The proportion of the effect that was explained by the potentially mediating biomarkers was defined as %β indirect effect = [(β − β 1 )/β] × 100, in which the effect (β) is the log (RR) of the association between high weight gain and colon cancer as estimated by a multivariable-adjusted model and the effect (β 1 ) denotes a multivariable-adjusted model plus the mediating variable. In epidemiology, this approach is referred to as "the difference of coefficients method" and was originally proposed by Freedman et al. (33) .
d The corresponding 95% CI was calculated on the basis of Fieller's theorem (35) . e The multivariable model in conditional logistic regression took into account the following matching factors: age, sex, study center, follow-up time since blood collection, time of day at blood collection, and fasting status; women were further matched on menopausal status and phase of the menstrual cycle at blood collection, and postmenopausal women were matched on use of hormone replacement therapy. The model was further adjusted for education (no school degree or primary school, technical or professional school, secondary school, university degree, or unknown), smoking status (never, past, current, or unknown), alcohol intake (g/day; continuous), and physical activity (inactive, moderately inactive, moderately active, active, or missing). The respective estimates for %ß indirect effects were as follows: waist circumference, 60%; C-reactive protein (CRP), 6%; C-peptide, 0%; hemoglobin A 1c (HbA1c), 24%; insulin-like growth factor 1 (IGF-1), 0%; high-molecular-weight (HMW) adiponectin, −11%; non-HMW adiponectin, 12%; leptin, 0%; soluble leptin receptor (sOB-R), 58%; high-density lipoprotein (HDL) cholesterol, 6%; triglycerides, −11%; total cholesterol, 0%; lowdensity lipoprotein (LDL) cholesterol, 0%; reactive oxygen metabolites (ROM), 6%; ferric reducing ability of plasma (FRAP), 6%; parathyroid hormone (PTH), 0%; vitamin D, 0%; iron, −17%; ferritin, −17%; and transferrin, 29%. Bars, 95% confidence intervals (CIs).
of 13%). The changes for ferritin (increase of 17%) and high-density lipoprotein cholesterol (reduction of 10%) were borderline significant. Attained BMI in adulthood and leptin attenuated the association by 24% and 21%, respectively; however, these changes did not prove to be statistically significant. No considerable changes in risk estimates were observed after we accounted for CRP, C-peptide, insulin-like growth factor 1, adiponectin, HMW adiponectin, triglycerides, total cholesterol, low-density lipoprotein cholesterol, parathyroid hormone, and vitamin D. Among the biomarkers, sOB-R, transferrin, and HbA1c further attenuated the association beyond waist circumference by 58%, 29%, and 24%, respectively (Figure 2) . In sensitivity analyses, no substantial differences from the main results were observed after exclusion of people diagnosed with cancer during the first 2 years of study follow-up, participants with diagnosed diabetes, and nonfasting participants (data not shown).
DISCUSSION
These data suggest that the association between adult weight gain and colon cancer is largely accounted for by attained abdominal fat accumulation and not by overall adiposity as represented by high BMI. The largest proportion of this association could be explained by HbA1c as a biomarker of altered glucose metabolism and sOB-R as a regulator of leptin bioavailability in blood circulation with effects on immunity, inflammation, and metabolism. Biomarkers of iron metabolism and oxidative stress may additionally mediate the association, albeit to a lesser extent.
Previously, we have shown that adult weight gain is associated with an increased risk of colon cancer in people with attained high waist circumference but not in those with a low waist circumference, whereas no such differences were seen by attained BMI (24) . In the current analysis, we extended these findings, showing that attained waist circumference mediates to a great extent the association between adult weight gain and colon cancer risk. The data supported 2 biomarkersHbA1c and sOB-R-as main metabolic mediators of the association between high adult weight gain and colon cancer.
Growing evidence suggests a close association between type 2 diabetes and various types of cancer, including colorectal cancer (36) . An elevated concentration of HbA1c-a biomarker of abnormal glucose metabolism-was suggested to primarily account for this association. Shared exposures such as diet and physical inactivity are unlikely to explain this association, as we controlled for these factors in all analyses and the findings remained unaltered. One could speculate that HbA1c has more direct effects. Thus, abnormal glucose metabolism, occurring when the body has difficulty processing glucose into energy, may be responsible for the excess glucose supply for glucose-hungry cells and may contribute to apoptosis resistance, carcinogenesis, and an overall malignant phenotype of cancer cells (37) .
sOb-R is the main binding protein for leptin in human blood and modulates its bioavailability (38) . High sOb-R concentrations were suggested to directly modulate leptin effects acting predominantly as inhibitors, whereas low sOb-R levels could serve as a potential indicator for the development of a leptin-resistant state in obesity (39) . Leptin is known to affect immunity by enhancing thymopoiesis and modulation of the T-cell immune response (40) , and recent evidence has suggested that its immune-system-modulatory effects are largely dependent on the level of leptin receptor expressed mostly in peripheral T-helper cells (41) . In our previous work, sOB-R statistically mediated the association between waist circumference and colon cancer, whereas no such effect was seen for leptin (27) .
Our data further revealed mediating roles for biomarkers of oxidative stress (ROM and FRAP). Obesity-induced inflammation is known to stimulate the increase of free radicals and subsequently promote oxidative stress, thus creating a microenvironment predisposing obese persons to tumor development (42) . Previously, we observed that biomarkers of oxidative stress statistically significantly mediate the association between waist circumference and colon cancer in men but not in women (43) . In the current analysis, we did not have sufficient statistical power to stratify the results of the analysis according to sex, and therefore we cannot answer the question as to whether the same sex-specific patterns could also be valid with regard to weight gain. Further large studies are needed to address this question.
Interestingly, our data suggested alterations in biomarkers of iron metabolism as another potential mechanism that may explain the relationship between weight gain and colon cancer. Iron homeostasis is affected by obesity and obesityrelated insulin resistance in a counterfactual manner. On the one hand, iron deficiency and anemia are common in obesity. On the other hand, in animal models, consumption of iron was shown to induce excessive weight gain and an increase in adipose tissue mass, as well as to promote oxidative stress and immune responses (44) . As opposed to preclinical findings for serum iron and cancer, population-based epidemiologic studies have shown an inverse association between iron metabolism and cancer risk (20, 45) . In our data, ferritin concentrations were inversely associated with weight gain and colon cancer, whereas transferrin concentrations were positively associated with both high weight gain and colon cancer.
Strengths of our study included the prospective design, the exploration of a wide range of biomarkers, and the detailed information on a number of dietary and lifestyle factors, which were used to control the analyses. Another major strength of this study was that most of the anthropometric measures assessed at study recruitment were directly measured in a standardized way. Thus, nondifferential misclassification of attained waist circumference and attained weight should have been minimal.
Some limitations of the current study should also be considered. First, we used long-term recall of body weight at age 20 years. Nevertheless, previous validation studies of self-reports of past body weight over a period similar to that used in our study showed moderate-to-strong correlations with measured weight in the range of 0.64-0.95 (46) , and the accuracy of self-reports has been generally supported in epidemiologic studies. It has been suggested that weight gain in early adulthood maybe more strongly associated with metabolic risk compared with increases in later adulthood (47) ; however, we were not able to differentiate between these time periods. Nevertheless, in a previous meta-analysis, we did not observe effect modification according to period of weight gain (early or late) (3). Biological pathways in obesity and metabolism may differ in men and women, and interpretation of our findings may be limited due to the lack of stratification by sex. However, in our data no statistically significant differences in the association between high weight gain and colon cancer risk could be seen by sex. Since some biomarkers are interrelated with each other, by adjusting for 1 biomarker we may also have partially accounted for the effect of 1 or more other, related markers. For the present analysis, we used availability of data as an inclusion criterion for study entry. Such a complete-case analysis may yield biased and inefficient estimates when the data are not missing completely at random (48) . However, we compared the baseline characteristics of the study participants with and without missing data and did not observe substantial differences. Finally, despite the biological plausibility of suggested mechanistic pathways, further research is needed to confirm causality assumptions.
In conclusion, these data suggest that the association between high adult weight gain and colon cancer could be primarily accounted for by attained abdominal fatness and the biomarkers HbA1c and sOB-R, representing pathways related to metabolic dysfunction. While targeting possible metabolic pathways for cancer is a challenge in cancer prevention, intensified efforts to control weight gain from early adulthood onward and to sustain metabolic health through lifestyle modifications remain existing alternative approaches.
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